Vontobel Holding Ltd. Lowers Position in Certara, Inc. (NASDAQ:CERT)

Vontobel Holding Ltd. trimmed its stake in Certara, Inc. (NASDAQ:CERT) by 16.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,264 shares of the company’s stock after selling 4,657 shares during the quarter. Vontobel Holding Ltd.’s holdings in Certara were worth $409,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. William Blair Investment Management LLC lifted its position in Certara by 1.1% during the third quarter. William Blair Investment Management LLC now owns 7,150,914 shares of the company’s stock valued at $103,974,000 after buying an additional 77,805 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Certara by 33.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,110,074 shares of the company’s stock valued at $30,680,000 after buying an additional 530,695 shares in the last quarter. Bamco Inc. NY lifted its position in Certara by 15.1% during the third quarter. Bamco Inc. NY now owns 1,069,103 shares of the company’s stock valued at $15,545,000 after buying an additional 140,000 shares in the last quarter. Rathbones Group PLC acquired a new position in Certara during the third quarter valued at approximately $11,007,000. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Certara by 48.8% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 727,240 shares of the company’s stock worth $10,574,000 after purchasing an additional 238,603 shares in the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently commented on CERT. KeyCorp raised shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price on the stock in a research report on Wednesday, April 10th. Jefferies Financial Group boosted their target price on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research report on Friday, March 1st. JMP Securities began coverage on shares of Certara in a research report on Thursday, April 4th. They set a “market perform” rating on the stock. Barclays boosted their target price on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. Finally, UBS Group boosted their target price on shares of Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research report on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Certara has a consensus rating of “Hold” and a consensus price target of $20.06.

Certara Stock Up 3.5 %

Shares of NASDAQ:CERT opened at $16.73 on Wednesday. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.28. The company has a fifty day simple moving average of $17.78 and a 200 day simple moving average of $16.22. The firm has a market cap of $2.68 billion, a PE ratio of -47.80, a price-to-earnings-growth ratio of 1.64 and a beta of 1.63. Certara, Inc. has a 12-month low of $11.81 and a 12-month high of $24.70.

Certara (NASDAQ:CERT) last released its earnings results on Thursday, February 29th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. The business had revenue of $88.01 million for the quarter, compared to the consensus estimate of $86.80 million. On average, equities research analysts anticipate that Certara, Inc. will post 0.29 EPS for the current fiscal year.

Insider Buying and Selling at Certara

In other Certara news, insider Patrick F. Smith sold 14,427 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now owns 50,091 shares in the company, valued at $844,033.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now owns 173,524 shares in the company, valued at $3,123,432. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total transaction of $243,094.95. Following the transaction, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The disclosure for this sale can be found here. Insiders sold a total of 23,427 shares of company stock worth $405,095 over the last 90 days. Insiders own 2.60% of the company’s stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.